Life Insurance
Consensus Index

AI Consensus Fit Review

Penn Mutual No-Exam or Accelerated Underwriting Indexed Universal Life Insurance Fit Review

Penn Mutual is a good fit for a healthy buyer who wants indexed universal life (IUL) and strongly prefers an underwriting path that may avoid a traditional paramedical exam.

Research: 2026-09-217 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Penn Mutual is a good fit for a healthy buyer who wants indexed universal life (IUL) and strongly prefers an underwriting path that may avoid a traditional paramedical exam. Two of seven platforms named Penn Mutual during the ranking stage, and six of seven returned a usable fit assessment. The strongest reason to consider it is the Accelerated Client Experience (ACE) program, which company materials describe as exam-free and lab-free for qualifying cases, with stated coverage up to $10 million and ages up to 65. The main limitation is verification risk: the recommended product names do not match current public Penn Mutual materials, pricing is not published, and no-exam treatment is conditional, not guaranteed.

Research Snapshot

FieldFinding
Platform mentions in ranking stage2 of 7 platforms (google, grok)
Share of included platform responses28.6%
Average listed rank3.0
Best listed rank1 (google)
Relevant product/model/planPenn Mutual IUL submitted through ACE; platform-named products were "Accumulation Builder II IUL" and "Diversified Advantage IUL," neither of which is clearly confirmed as a current IUL offering
Overall use-case fitGood, with a product-verification caveat
Research date2026-09-21

Why Penn Mutual Qualified for This Study

Questions This Section Answers

  • Is Penn Mutual a good choice for no-exam or accelerated underwriting indexed universal life insurance?
  • Why did only two AI platforms name Penn Mutual for no-exam IUL coverage?

Penn Mutual qualified because it combines a genuine accelerated-underwriting pathway with a permanent IUL product category and a long carrier history. Two of seven included platforms named it during ranking discovery, and six of seven returned a usable fit assessment. Google ranked it first; grok ranked it fifth.

The company states it has operated since 1847 and reports ratings from AM Best, Moody's, S&P, and Kroll [1]. AM Best affirmed an A+ (Superior) financial strength rating and aa- long-term issuer credit ratings for Penn Mutual and its subsidiaries on April 1, 2025 [2]. Penn Mutual states it has earned an A or higher Financial Strength Rating from AM Best for 99 consecutive years [3]. Company-published figures as of December 31, 2025 report $3 billion in life and annuity benefits paid, $4.3 billion in total surplus, and $64 billion in assets under control (official:C1). These are company-reported figures, not independently verified.

Independent reviews support the carrier-strength picture. One review describes Penn Mutual as a solid, financially stable company with over 175 years in business and an A+ rating from AM Best [4]. Another cites strong financial strength ratings from AM Best and Moody's [5]. A third notes high financial strength ratings from major rating agencies [6].

Independent complaint data is favorable. Penn Mutual received only 3% of the customer complaints expected for its size, according to the National Association of Insurance Commissioners [7]. A separate review reports an NAIC Complaint Index of 0.05 against an industry average of 1.00 [8].

The consensus index for this category is No-Exam or Accelerated Underwriting Indexed Universal Life Insurance.

The Product, Model, Plan, or Service Most Relevant to No-Exam or Accelerated Underwriting Indexed Universal Life Insurance

Questions This Section Answers

  • Which Penn Mutual IUL product should a buyer request if they want accelerated underwriting without a paramedical exam?
  • Is Penn Mutual's Diversified Advantage an indexed universal life policy or a variable universal life policy?
  • Is Penn Mutual's Accumulation Builder II IUL still available in 2026?

The most relevant Penn Mutual offering is an accumulation-oriented IUL submitted through the Accelerated Client Experience (ACE). The exact contract name is unresolved and must be confirmed before purchase.

ACE is the underwriting engine. Penn Mutual states that, in most cases, accelerated underwriting means no intrusive medical exam, fluid tests, APS requirements, or phone interview, and that ACE is unavailable in New York and for certain product categories [9]. ACE supports electronic application, signatures, payment, and delivery, with policies potentially issued in as little as a few hours [10]. Penn Mutual describes accelerated underwriting without exams or lab tests for approved cases up to $10 million on most life products [11]. ACE is available with most term and permanent single-life products [12], and Penn Mutual's application submission flow includes indexed universal life under ACE [13].

The product-name conflict is material. Penn Mutual announced Accumulation Indexed Universal Life as a permanent life product with cash accumulation potential and indexed-account choices [14]. Current public Penn Mutual product portfolio materials list Accumulation IUL and Diversified Advantage VUL as separate categories [15], and the Diversified Advantage prospectus identifies it as Variable Universal Life rather than IUL [16]. Independent reviews identify the current Accumulation Builder line as Accumulation Builder Flex IUL, issued by The Penn Insurance and Annuity Company [17], and Accumulation Builder Select IUL [18]. One review states that "Accumulation Builder II IUL" does not appear in current 2025–2026 marketing materials or independent reviews.

Platforms named "Accumulation Builder II IUL" and "Diversified Advantage IUL" as the relevant plans, but current public Penn Mutual materials do not clearly establish either as a current IUL offering. Treat the platform-named product as unverified until Penn Mutual confirms the exact contract form.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Penn Mutual's no-exam underwriting limits and age range?
  • How fast can Penn Mutual issue an IUL policy through accelerated underwriting?

Platforms broadly agreed on four points: ACE exists, it can avoid exams and labs for qualifying cases, it carries a high stated coverage ceiling, and it is unavailable in New York.

On the no-exam pathway, Penn Mutual's own materials state that ACE can be exam-free and lab-free, using health questions plus motor vehicle records, MIB, LexisNexis, and prescription checks, with eligibility stated as ages 0–65 and up to $10 million less in-force coverage [19]. Independent reviews describe no-exam underwriting for qualified applicants ages 20–65 with face amounts up to $10 million [21], and one calls the age-65 no-exam ceiling "one of the highest no-exam age limits in our analysis" [22]. Another states that most insurers cap no-exam coverage at $1 million to $3 million, while Penn Mutual's no-exam limit matches its standard coverage maximum of $10 million [23].

On speed, Penn Mutual markets ACE as shortening issue time and, in some approved cases, issuing policies in a few hours [24]. Independent coverage reports approvals in as quick as 24 hours for qualified applicants [25].

On product design, Penn Mutual IUL materials describe indexed accounts, a fixed account, downside floors on indexed accounts, monthly crediting, an indexed loan option, a no-lapse guarantee, and policy-value enhancement features [27]. Independent reviews describe level or increasing death benefit options, issue ages 0 to 85, and a no-lapse guarantee of up to 30 years or until age 85 [28]. One review states that Penn Mutual is considered one of the stronger carriers for indexed universal life insurance and that its Accumulation Builder products offer competitive cap rates, downside protection, and multiple indexing options [30].

On geography, Penn Mutual states ACE is not available in New York [32], and product materials state that products may not be available in all states and are not offered in New York [33].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Why do AI platforms disagree about which Penn Mutual IUL product is current?
  • Is Penn Mutual's no-exam underwriting limited to certain risk classes?

Platforms disagreed or stayed silent on product identity, risk-class eligibility, pricing, and early cash value performance.

The product-name conflict is the largest uncertainty. Platforms named "Accumulation Builder II IUL" and "Diversified Advantage IUL," but current public Penn Mutual materials identify Diversified Advantage as VUL [34] and list Accumulation IUL and Diversified Advantage VUL as separate categories [35]. Independent reviews identify Accumulation Builder Flex IUL and Accumulation Builder Select IUL as the current Accumulation Builder products [36]. One platform states plainly that the recommended product "does not appear in current 2025–2026 marketing materials or independent reviews."

Risk-class eligibility is also unresolved. One review states that people with better risk classes can qualify for exceptional accelerated underwriting that requires no medical exam [38], implying a risk-class restriction. Penn Mutual's own FAQ states eligibility as Standard or better risk classes [39]. Other sources describe no-exam availability for "qualified applicants" ages 20–65 without explicit risk-class language [40]. The controlling underwriting guide was not publicly located.

Pricing transparency is a third gap. U.S. News reports that the company does not provide online quotes or applications and that applicants must speak directly with a financial professional [41]. One review states that pricing data for Penn Mutual is not available, while another provides term-life pricing examples from comparison data. No platform produced a verified current IUL premium illustration.

Early cash value performance drew one conflicting claim. One source states that Penn Mutual IUL shows lower early cash value compared to some competitors in years 1–6, but provides no comparative quantification. Other sources emphasize Penn Mutual as a strong performer without caveating early years.

Finally, one platform (deepseek) ran with search disabled and a research date of 2026-01-15, eight months before the authoritative run date. Its claims are platform-reported and should be treated as less current than the search-enabled platforms.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What underwriting data does Penn Mutual's ACE program review instead of a paramedical exam?
  • Does Penn Mutual's accelerated underwriting guarantee no medical exam?

Penn Mutual's use-case fit rests on three capabilities: a data-driven accelerated underwriting pathway, a high stated coverage ceiling, and a permanent IUL chassis with indexed crediting and downside floors. None of these is a guarantee.

The underwriting pathway substitutes data for exams. Penn Mutual states accelerated underwriting decisions are based on its underwriting criteria, life and health questions, motor vehicle report, MIB search, LexisNexis risk score, and pharmaceutical check [43]. One platform reports that 75% of accelerated cases were rated Preferred or better, and that an APS may be accepted in lieu of an exam if a recent physical exists [44]. These are platform-reported figures.

The coverage ceiling is high relative to peers. Penn Mutual materials state that cases up to $10 million and age 65 may qualify for accelerated underwriting, while another current Penn Mutual source describes coverage up to $10 million on most life products [46]. Independent reviews describe no-exam underwriting for qualified applicants up to $10 million as "one of the highest no-exam limits in the market" [48] and note that this makes Penn Mutual one of the few options for high-net-worth applicants who want to skip the medical exam [49].

The IUL chassis includes indexed accounts, a fixed account, downside floors, monthly crediting, an indexed loan option, a no-lapse guarantee, and policy-value enhancement features [50]. One product launch describes five diverse indexed account options, each with built-in guarantees, designed to perform uniquely across multiple market scenarios [51], and a guarantee of at least 1% interest growth [52]. Minimum coverage starts at $50,000 through age 70 and $100,000 for ages 71 and older [53].

The critical caveat: no-exam treatment is conditional. Penn Mutual does not guarantee a no-exam process for all applicants, and some applicants may still be required to complete a paramedical exam based on age, coverage amount, or health history [55]. One review notes that qualifying for accelerated underwriting does not guarantee an exam waiver, and an exam may still be requested if additional information is needed [56].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Penn Mutual IUL cost per month, and are there setup or cancellation fees?
  • What policy charges and surrender terms should a buyer confirm before signing a Penn Mutual IUL contract?

Penn Mutual does not publish IUL premiums, cost-of-insurance tables, or a standard ACE fee schedule. Pricing confidence across platforms is low, and no verified current premium illustration was produced.

No public consumer premium schedule, guaranteed-cost table, or standard ACE fee schedule was identified (openai). Penn Mutual does not provide online life insurance quotes, so pricing must be obtained through a financial professional [57]. One platform reports that no separate application or ACE fee was verified in the retrieved sources (perplexity).

Platform-reported cost components include cost-of-insurance charges that vary by age, health, and death benefit option; administrative fees charged against policy cash value; rider charges if optional riders are elected; and indexed crediting subject to cap rates and participation rates that can change (anthropic). One platform reports premium loads of 8% in year one and 5% thereafter (maximum 8%), monthly fees of $9 in year one and $5 thereafter, per-$1,000 expense charges in the first 10 years, and surrender charges (grok). Another reports indexed account rates as of September 2026 including a capped 1-year account at 9.25% with a 1% floor and 100% participation, and a loan net cost of 1% in years 1–5 and 0% in years 6 and later (grok). These figures are platform-reported and were not independently verified.

Contract terms vary by policy form and state. Product provisions, surrender charges, guarantees, loan terms, and rider availability vary by policy form and state, and accessing cash value may create charges, reduce death benefit or policy values, and require additional premiums to prevent lapse (openai). Unpaid policy loans may void the no-lapse guarantee (anthropic). No-lapse guarantees run up to 30 years or until age 85, whichever is sooner, for accumulation-based IUL, and up to 20 years or until age 80 for survivorship IUL (anthropic).

Industry context: one review states that no-exam IUL typically costs 10–30% more than fully underwritten coverage [58], and another reports typical IUL premiums of $800–$1,200 per month for a $500,000 death benefit, with realistic returns of 3–5% versus illustrated 7–9% [59]. These are generic industry figures, not Penn Mutual quotes.

Best Suited For

Questions This Section Answers

  • Who is Penn Mutual's no-exam IUL best suited for?
  • What coverage amount and age profile fits Penn Mutual's accelerated underwriting best?

Penn Mutual is best suited to healthy applicants ages 20–65 who want permanent IUL coverage, need a potentially exam-free process, and are willing to work through a licensed financial professional.

The strongest fit is a healthy applicant seeking permanent coverage who is willing to answer health questions and permit electronic data, prescription, and medical-record review (openai). Penn Mutual states that ACE is available with most term and permanent single-life products and supports coverage up to $10 million in stated circumstances, making it potentially relevant for substantial permanent coverage [60].

A second fit is a buyer who wants meaningful coverage without an exam. Independent reviews describe no-exam underwriting for qualified applicants up to $10 million as one of the highest no-exam limits in the market [62], and note that most insurers cap no-exam coverage at $1 million to $3 million [63].

A third fit is a buyer who values carrier longevity and mutual-company structure but will obtain a current illustration and policy cost comparison (openai). One review notes that Penn Mutual is considered one of the stronger carriers for indexed universal life insurance [64].

A fourth fit is a buyer who wants conversion flexibility. One review describes superior term-to-permanent conversion features, including a generous conversion window and the ability to convert to any Penn Mutual permanent product including IUL [65].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Penn Mutual for no-exam or accelerated underwriting IUL?
  • Is Penn Mutual a poor fit for buyers who need guaranteed no-exam issuance?

Penn Mutual is probably not the best fit for New York residents, applicants over 65, buyers who need guaranteed no-exam issuance, and buyers who prioritize transparent online pricing or the lowest possible premium.

New York residents are excluded. Penn Mutual states ACE is unavailable in New York [66], and product materials state that products are not offered in New York [68].

Applicants over 65 fall outside the no-exam window. Eligible ages for no-exam applications are 0–65, and applicants over 65 must undergo traditional underwriting with a medical exam [69]. One platform states that applicants over age 65 or seeking coverage above $10 million must undergo traditional medical underwriting (anthropic).

Buyers who need guaranteed no-exam issuance are a poor fit. No-exam treatment is conditional, not guaranteed, and some applicants may still be required to complete a paramedical exam based on age, coverage amount, or health history [71].

Buyers who want self-service purchasing are a poor fit. Penn Mutual does not offer online quotes or online applications, and applicants must speak directly with a financial professional [72]. One review notes that the online portal exists only for existing policyholders [69].

Buyers with complex medical history may also struggle. One review states that with tight underwriting guidelines, Penn Mutual doesn't make it easy to obtain coverage [74].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Penn Mutual for a buyer who lives in New York and needs no-exam IUL?
  • When is a fully underwritten policy or a different carrier a better choice than Penn Mutual?

Another option may be better in five situations: New York residency, coverage above $10 million, age above 65, a preference for digital-first self-service, and a preference for published crediting structures.

For New York residents, alternatives include New York Life, Guardian, or other NY-licensed IUL carriers (anthropic). Penn Mutual does not offer IUL in New York (anthropic).

For applicants over 65 or seeking coverage above $10 million without a medical exam, other carriers may offer higher age limits or coverage caps for no-exam underwriting (anthropic). One platform names United Life LegacyAccel as an alternative for ages 18–85 with no medical testing unless net amount at risk exceeds stated thresholds [76].

For buyers who want a fully self-directed online experience, digital-native insurers provide accelerated underwriting with online application and quote capability (anthropic). Penn Mutual requires advisor involvement [77].

For buyers who want published crediting structures, one platform points to Prudential PruLife Index Advantage IUL, which publishes a 0% floor, 100% participation rate, a 30% guaranteed maximum spread, a 3% guaranteed minimum, and an uncapped indexed account option [78]. Penn Mutual's specific IUL crediting parameters were not found in the supplied sources.

For buyers who prioritize the lowest possible premium and are healthy enough for full underwriting, traditional underwriting may yield better rates (kimi). One review states that no-exam IUL typically costs 10–30% more than fully underwritten coverage [79].

For buyers who want guaranteed cash value growth without indexing volatility, Penn Mutual whole life or non-indexed universal life may be more appropriate (anthropic).

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Penn Mutual before signing an IUL contract?
  • Which product, state, and underwriting details must be verified in writing before purchase?

Verify these items in writing before signing:

  1. Is the proposed contract Accumulation Builder II IUL, Accumulation IUL, Accumulation Builder Flex IUL, Accumulation Builder Select IUL, another current IUL, or Diversified Advantage VUL? (openai, anthropic)
  2. Is the exact product eligible for ACE in the applicant's state? (openai)
  3. What are the current accelerated-underwriting age, face-amount, health-history, replacement, citizenship, and residence requirements? (openai)
  4. Will the case require an exam, labs, APS, or phone interview after electronic data review? (openai)
  5. Which medical, prescription, MIB, consumer-report, and electronic-record sources will be accessed, and what consent or dispute rights apply? (openai)
  6. Are specific risk classifications required to qualify for no-exam underwriting, or is it available for all health classes aged 20–65? (anthropic)
  7. What are the guaranteed and current illustrated values at multiple premium levels and crediting assumptions? (openai)
  8. What are the cap rates, participation rates, spreads, indexed-account charges, loan rates, surrender charges, and no-lapse requirements? (openai)
  9. What happens if premiums are reduced, skipped, or paid late? (openai)
  10. What are the current AM Best, Moody's, S&P, and Kroll ratings and outlooks for the issuing company? (openai)
  11. Is any coverage already in force with Penn Mutual counted against the $10 million accelerated-underwriting limit? (perplexity)
  12. What premium is required to prevent policy lapse under conservative return assumptions rather than illustrated assumptions? (kimi)

Final AI Consensus Verdict

Good fit, with an important product-verification caveat. Penn Mutual appears well suited to a healthy consumer who wants IUL and strongly prefers a potentially no-exam, digitally accelerated underwriting process. The strongest evidence supports ACE rather than the exact named IUL products. Six of seven included platforms returned a usable fit assessment, and fit ratings ranged from "good" to "strong." That agreement reflects platform opinion, not proof of product quality.

The case for Penn Mutual rests on a genuine accelerated-underwriting pathway, a stated $10 million coverage ceiling, ages up to 65, an end-to-end digital workflow, a permanent IUL chassis with indexed accounts and downside floors, and a long carrier history with reported A+ financial strength. The case against relying on it without verification rests on unresolved product naming, conditional no-exam treatment, no published pricing, no online application, New York unavailability, and non-guaranteed IUL illustration assumptions.

Confirm the current contract, state eligibility, underwriting thresholds, policy charges, and guaranteed-versus-illustrated values before purchase.

How This Review Was Produced

This review was produced from supplied AI-platform research responses collected for the topic "Best No-Exam or Accelerated Underwriting Indexed Universal Life Insurance." Seven platforms were configured; six returned a usable fit assessment for Penn Mutual. Two platforms named Penn Mutual during the ranking stage.

The report evaluates Penn Mutual only for the no-exam or accelerated underwriting IUL use case. It is not a broad company review. Fit ratings, product names, pricing figures, and underwriting parameters are reproduced as platform-reported evidence and were not independently verified by the writer stage. Company-owned citations materially outnumber independent citations in the supplied evidence, so company claims should not be read as independently confirmed.

The category directory for life insurance lists related coverage areas.

Methodology Limitations

Several limitations apply.

First, only two of seven platforms named Penn Mutual during ranking discovery, and six of seven returned a usable fit assessment. Fit findings should not be described as unanimous.

Second, platform-reported research dates differ from the authoritative run date of 2026-09-21. One platform (deepseek) ran with search disabled and a research date of 2026-01-15. Platform-reported dates are provenance metadata and do not independently prove freshness.

Third, the supplied URLs were collected from platform responses and were not independently validated by the writer stage.

Fourth, company-owned citations materially outnumber independent citations. Company claims are not independently verified.

Fifth, citations are platform-reported evidence, not independently verified facts. No-search model claims require explicit verification before being described as current facts.

Sixth, conflicting product names, pricing, and capabilities were not resolved by guessing. The conflict is described, and buyers are told what to verify.

Seventh, current financial-strength rating grades, product-specific premiums, detailed expense schedules, and complete underwriting data rules were not established from the sources reviewed.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • Additional AI research evidence79 records
    1. AI research evidence record openai:c8
    2. AI research evidence record anthropic:29-1
    3. AI research evidence record anthropic:33-1
    4. AI research evidence record anthropic:25-1
    5. AI research evidence record anthropic:22-12
    6. AI research evidence record deepseek:cit_4
    7. AI research evidence record anthropic:11-1
    8. AI research evidence record anthropic:21-4
    9. AI research evidence record openai:c1
    10. AI research evidence record openai:c2
    11. AI research evidence record openai:c3
    12. AI research evidence record perplexity:c2
    13. AI research evidence record perplexity:c5
    14. AI research evidence record openai:c4
    15. AI research evidence record openai:c6
    16. AI research evidence record openai:c5
    17. AI research evidence record anthropic:2-5
    18. AI research evidence record anthropic:5-1
    19. AI research evidence record perplexity:c1
    20. AI research evidence record grok:5
    21. AI research evidence record anthropic:4-3
    22. AI research evidence record anthropic:21-3
    23. AI research evidence record anthropic:21-11
    24. AI research evidence record perplexity:c2
    25. AI research evidence record anthropic:4-5
    26. AI research evidence record kimi:terminsurancebrokers1
    27. AI research evidence record openai:c7
    28. AI research evidence record anthropic:1-17
    29. AI research evidence record anthropic:10-1
    30. AI research evidence record anthropic:25-8
    31. AI research evidence record anthropic:25-9
    32. AI research evidence record openai:c1
    33. AI research evidence record anthropic:41-6
    34. AI research evidence record openai:c5
    35. AI research evidence record openai:c6
    36. AI research evidence record anthropic:2-5
    37. AI research evidence record anthropic:5-1
    38. AI research evidence record anthropic:1-1
    39. AI research evidence record perplexity:c1
    40. AI research evidence record anthropic:21-10
    41. AI research evidence record anthropic:11-2
    42. AI research evidence record anthropic:11-3
    43. AI research evidence record perplexity:c1
    44. AI research evidence record grok:0
    45. AI research evidence record grok:5
    46. AI research evidence record openai:c2
    47. AI research evidence record openai:c3
    48. AI research evidence record anthropic:21-9
    49. AI research evidence record anthropic:21-12
    50. AI research evidence record openai:c7
    51. AI research evidence record anthropic:19-4
    52. AI research evidence record anthropic:19-3
    53. AI research evidence record anthropic:1-18
    54. AI research evidence record anthropic:20-1
    55. AI research evidence record deepseek:cit_1
    56. AI research evidence record kimi:investopedia1
    57. AI research evidence record anthropic:20-11
    58. AI research evidence record kimi:starwest1
    59. AI research evidence record kimi:insurancebyheroes1
    60. AI research evidence record openai:c1
    61. AI research evidence record openai:c2
    62. AI research evidence record anthropic:21-9
    63. AI research evidence record anthropic:21-11
    64. AI research evidence record anthropic:25-8
    65. AI research evidence record kimi:wsj1
    66. AI research evidence record openai:c1
    67. AI research evidence record perplexity:c2
    68. AI research evidence record anthropic:41-6
    69. AI research evidence record kimi:investopedia1
    70. AI research evidence record kimi:wsj1
    71. AI research evidence record deepseek:cit_1
    72. AI research evidence record anthropic:11-2
    73. AI research evidence record anthropic:11-3
    74. AI research evidence record anthropic:9-8
    75. AI research evidence record anthropic:14-16
    76. AI research evidence record kimi:unitedlife1
    77. AI research evidence record anthropic:11-3
    78. AI research evidence record kimi:prudential1
    79. AI research evidence record kimi:starwest1

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 21, 2026
Platforms analyzed
7
Source records
42
Ranking mentions
2 of 7
Platform share
29%
Final consensus rank
#8

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

17 independent · 24 company-owned · 1 unclear

Evidence support

33 direct · 9 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

a4876dba91a404109f12fbbcf2e475d9b860db7ca52be8bff1eda6810f512480